YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Sun Pharmaceutical Industries

Sun Pharmaceutical Industries

BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 27, 16:00
511.55
-0.05 (-0.01%)
VOLUME 224,645
LIVE
NSE
Nov 27, 15:59
511.65
-0.05 (-0.01%)
VOLUME 12,954,065
News on Sun Pharmaceutical Industries
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Sun Pharmaceutical Industries; target of Rs 585: ICICI Direct

1.40 pm | 07 Nov 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 585 in its research report ...

Buy Sun Pharmaceutical Industries; target of Rs 597: Prabhudas Lilladher

4.44 pm | 06 Nov 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 597 in its research ...

Buy Sun Pharmaceutical Industries: target of Rs 612: Sharekhan

5.07 pm | 05 Nov 2020 |  Source: Moneycontrol.com

Sharekhan is bullish on Sun Pharmaceutical Industries recommended buy rating on the stock with a target price of Rs 612 in its research report dated N...

Trade Spotlight: Sun Pharma, CARE Ratings and Alok Industries in focus

8.28 am | 05 Nov 2020 |  Source: Moneycontrol.com

Stocks like Sun Pharma rose nearly 4 percent, CARE Ratings rallied by about 20 percent, and Alok Industries closed with gains of about 5 percent on We...

Sun Pharma Consolidated September 2020 Net Sales at Rs 8,553.13 crore, up 5.29% Y-o-Y

11.22 am | 04 Nov 2020 |  Source: Moneycontrol.com

NULL...

What should investors do with Sun Pharma post Q2: buy, sell or hold?

10.04 am | 04 Nov 2020 |  Source: Moneycontrol.com

The drug major on November 3 reported a 70.4 percent year-on-year growth in consolidated profit, driven by operating performance and tax credit though...

Sun Pharma: Traction in select speciality comes as a surprise

9.07 am | 04 Nov 2020 |  Source: Moneycontrol.com

Though valuation is still not inexpensive, we see improved trade sentiment for Sun Pharma post results. Sustained traction in speciality will be a key...

Reduce Sun Pharmaceutical Industries; target of Rs 476: Prabhudas Lilladher

4.35 pm | 03 Nov 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher recommended Reduce rating on Sun Pharmaceutical Industries with a target price of Rs 476 in its research report dated October 30, ...

Sun Pharma Q2 earnings beat the Street as profit surges 70% to Rs 1,813 crore

3.29 pm | 03 Nov 2020 |  Source: Moneycontrol.com

Consolidated revenue from operations grew by 5.3 percent year-on-year to Rs 8,553 crore in September quarter....

Sun Pharma Q2 preview: Taro may hit revenue growth, trends in specialty portfolio key to watch

7.37 am | 03 Nov 2020 |  Source: Moneycontrol.com

Sun Pharma's key facility Halol continues to be under FDA issue which has slowed down new approvals....

Buy Sun Pharmaceuticals; target of Rs 660: Dolat Capital

2.38 pm | 21 Sep 2020 |  Source: Moneycontrol.com

Dolat Capital is bullish on Sun Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 660 in its research report dated Sep...

Buy Sun Pharmaceutical Industries; target of Rs 625: ICICI Direct

12.59 pm | 10 Aug 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 625 in its research report ...

Buy Sun Pharmaceuticals; target of Rs 571: Dolat Capital

9.14 pm | 09 Aug 2020 |  Source: Moneycontrol.com

Dolat Capital is bullish on Sun Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 571 in its research report dated Aug...

Buy Sun Pharma; target of Rs 619 KRChoksey

9.02 am | 09 Aug 2020 |  Source: Moneycontrol.com

KRChoksey is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 619 in its research report dated August 07, 2020....

Hold Sun Pharma; target of Rs 542: Emkay Global Financial

2.42 pm | 08 Aug 2020 |  Source: Moneycontrol.com

Emkay Global Financial recommended hold rating on Sun Pharma with a target price of Rs 542 in its research report dated July 31, 2020....

Reduce Sun Pharmaceutical Industries; target of Rs 479: Prabhudas Lilladher

12.32 pm | 08 Aug 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher recommended reduce rating on Sun Pharmaceutical Industries with a target price of Rs 479 in its research report dated August 02, 2...

Hold Sun Pharmaceuticals Industries; target of Rs 575: Sharekhan

2.15 pm | 07 Aug 2020 |  Source: Moneycontrol.com

Sharekhan recommended Hold rating on Sun Pharmaceuticals Industries with a target price of Rs 575 in its research report dated July 31, 2020....

Buy Sun Pharma; target of Rs 625: Motilal Oswal

1.42 pm | 07 Aug 2020 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 625 in its research report dated August 01, 2020....

Hold Sun Pharmaceutical Industries; target of Rs 479: Prabhudas Lilladher

1.59 pm | 03 Aug 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 479 in its research report dated July 31, 2020....

Sun Pharma’s steady India business and US speciality portfolio should help it do well in FY22

9.47 am | 03 Aug 2020 |  Source: Moneycontrol.com

What adds to the Sun Pharma's investment case is the prospect for US specialty. The management hopes to achieve EBITDA break-even for a few produc...

1 2
Quick Links for Sun Pharmaceutical Industries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.